Spinal Cord and Brain

Novel noninvasive neuromodulation
therapies for unmet clinical needs

About SpineX

SpineX Inc. is an early stage bioelectric medtech company developing Noninvasive Neuromodulation devices. We are committed to helping individuals with unmet clinical needs. Our goal is to use rigorously tested neuromodulation technologies to aid recovery and restoration of bladder, bowel, respiration, sexual and sensorimotor function for individuals Stroke, Spinal Cord Injuries, Multiple Sclerosis, Tramatic Brain Injury, Cerebral Palsy and other neurological conditions.

Meet The Team

Parag Gad, PhD
Co-Founder and CEO
Evgeniy Kreydin, MD
Reggie Edgerton, PhD
Gabe Kalmar, PhD
Tim Hopper, MBA


Spinal Neuromodulation is a platform technology and is being developed for use in adults and pediatrics.

Spinal Cord Innovation in Pediatrics

SCiP device is a non-invasive spinal cord neuromodulation device to treat the underlying neurological dysfunction related to Cerebral Palsy.

SCiP has been recognized by FDA as a Breakthrough Device.

Spinal Cord Neuromodulator

SCONE™ is delivers proprietary modulated waveforms of varying currents to designated areas of the spine in a specific sequence via hydrogel electrodes directly over the skin without causing any pain or discomfort to the user and is intended to treat Neurogenic Bladder due to Stroke, Spinal Cord Injury or Multiple Sclerosis.

SCONE™ has been recognized by FDA as a Breakthrough Device.

SCONE™ and SCiP are investigational devices and are limited by Federal (USA) law to investigational use only. FDA has not reviewed their safety and effectiveness.

Connect with SpineX